Cargando…
Adjunctive aerosolized colistin for multi-drug resistant gram-negative pneumonia in the critically ill: a retrospective study
BACKGROUND: The incidence of multi-drug resistant (MDR) gram-negative (GN) organisms including Pseudomonas and Acinetobacter spp has increased in the last decade, prompting re-evaluation of colistin for the management of these infections. Aerosolized colistin as an adjunct to intravenous therapy is...
Autores principales: | Doshi, Neha M, Cook, Charles H, Mount, Kari L, Stawicki, Stanislaw P, Frazee, Erin N, Personett, Heather A, Schramm, Garrett E, Arnold, Heather M, Murphy, Claire V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4175116/ https://www.ncbi.nlm.nih.gov/pubmed/24274315 http://dx.doi.org/10.1186/1471-2253-13-45 |
Ejemplares similares
-
Circulatory Support with Venoarterial ECMO Unsuccessful in Aiding Endogenous Diltiazem Clearance after Overdose
por: Frazee, Erin N., et al.
Publicado: (2014) -
Predictors of mortality among bacteremic patients with septic shock receiving appropriate antimicrobial therapy
por: Leedahl, David D, et al.
Publicado: (2014) -
The significance of different formulations of aerosolized colistin
por: Michalopoulos, Argyris, et al.
Publicado: (2005) -
Risk factors of colistin safety according to administration routes: Intravenous and aerosolized colistin
por: Min, Kyoung Lok, et al.
Publicado: (2018) -
Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis
por: Michalopoulos, Argyris, et al.
Publicado: (2005)